Literature DB >> 27803642

>CME/CNE ARTICLE: Severity Grading in Multiple Sclerosis: A Proposal.

Robert Charlson, Joshua Herbert, Ilya Kister.   

Abstract

Currently used classification schemes for multiple sclerosis (MS) have not taken into account disease severity, instead focusing on disease phenotype (ie, relapsing vs. progressive). In this article, we argue that disease severity adds a crucial dimension to the clinical picture and may help guide treatment decisions. We outline a practical, easy-to-implement, and comprehensive scheme for severity grading in MS put forward by our mentor, Professor Joseph Herbert. We believe that severity grading may help to better prognosticate individual disease course, formulate and test rational treatment algorithms, and enhance research efforts in MS.

Entities:  

Year:  2016        PMID： 27803642      PMCID： PMC5087582          DOI： 10.7224/1537-2073.2015-097

Source DB:  PubMed          Journal:  Int J MS Care        ISSN： 1537-2073


  16 in total

1.  Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.

Authors:  J Fagius; J Lundgren; G Oberg
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

Review 2.  Aggressive multiple sclerosis: proposed definition and treatment algorithm.

Authors:  Carolina A Rush; Heather J MacLean; Mark S Freedman
Journal:  Nat Rev Neurol       Date:  2015-06-02       Impact factor: 42.937

3.  Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system.

Authors:  S Poser; J Wikström; H J Bauer
Journal:  J Neurol Sci       Date:  1979-02       Impact factor: 3.181

4.  Characterising aggressive multiple sclerosis.

Authors:  Suresh Menon; Afsaneh Shirani; Yinshan Zhao; Joel Oger; Anthony Traboulsee; Mark S Freedman; Helen Tremlett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-06       Impact factor: 10.154

5.  Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.

Authors:  S A Hawkins; G V McDonnell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

6.  Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Authors:  R H S R Roxburgh; S R Seaman; T Masterman; A E Hensiek; S J Sawcer; S Vukusic; I Achiti; C Confavreux; M Coustans; E le Page; G Edan; G V McDonnell; S Hawkins; M Trojano; M Liguori; E Cocco; M G Marrosu; F Tesser; M A Leone; A Weber; F Zipp; B Miterski; J T Epplen; A Oturai; P Soelberg Sørensen; E G Celius; N Téllez Lara; X Montalban; P Villoslada; A M Silva; M Marta; I Leite; B Dubois; J Rubio; H Butzkueven; T Kilpatrick; M P Mycko; K W Selmaj; M E Rio; M Sá; G Salemi; G Savettieri; J Hillert; D A S Compston
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

7.  A disease severity scale for systemic sclerosis: development and testing.

Authors:  T A Medsger; A J Silman; V D Steen; C M Black; A Akesson; P A Bacon; C A Harris; S Jablonska; M I Jayson; S A Jimenez; T Krieg; E C Leroy; P J Maddison; M L Russell; R K Schachter; F A Wollheim; H Zacharaie
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

8.  Longitudinal follow-up of "benign" multiple sclerosis at 20 years.

Authors:  Ana-Luiza Sayao; Virginia Devonshire; Helen Tremlett
Journal:  Neurology       Date:  2007-02-13       Impact factor: 9.910

9.  Disability in multiple sclerosis: a reference for patients and clinicians.

Authors:  Ilya Kister; Eric Chamot; Amber R Salter; Gary R Cutter; Tamar E Bacon; Joseph Herbert
Journal:  Neurology       Date:  2013-02-20       Impact factor: 9.910

10.  Development and validation of a fetal cardiovascular disease severity scale.

Authors:  Brooke T Davey; Mary T Donofrio; Anita J Moon-Grady; Carlen G Fifer; Bettina F Cuneo; Christine B Falkensammer; Anita L Szwast; Jack Rychik
Journal:  Pediatr Cardiol       Date:  2014-05-07       Impact factor: 1.655
View more
  3 in total

1.  Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: A register-based prospective study in Sweden.

Authors:  Greta Bütepage; Ahmed Esawi; Kristina Alexanderson; Emilie Friberg; Chantelle Murley; Jan Hillert; Korinna Karampampa
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-10-23

2.  Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment era.

Authors:  Ilya Kister; Tamar E Bacon; Gary R Cutter
Journal:  Ther Adv Neurol Disord       Date:  2018-09-11       Impact factor: 6.570

3.  Seasonal variability of serum 25-hydroxyvitamin D on multiple sclerosis onset.

Authors:  Ingrid Kockum; Jesse Huang; Pernilla Stridh
Journal:  Sci Rep       Date:  2021-10-25       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.